Jonas from Spain

Registered at the short selling broker Skilling, 4 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

Takeda Pharmaceutical Co., Ltd (TAK) shares information

Takeda Pharmaceutical Co – ADR

24h Change

1.53 %


Live rate: Market closed

Stock data per Friday 25 Nov, 2022

0.22 (+ 1.53%)
US Market is closed

Live Stock price in graph for Takeda Pharmaceutical Co – ADR (TAK)

  • Latest Volume

    1,210,362 (-29.47 %)

  • Volume prev. day


  • Avg. daily volume


  • Market cap


  • P/E ratio


  • Today high

    14.6 USD

  • Today low

    14.37 USD

  • 52 week high

    15.18 USD

  • 52 week low

    12.28 USD

  • YTD Change

    + 10.93 %

Quick links


Latest news about Takeda Pharmaceutical Co – ADR

Below you can find the most recent news posts about Takeda Pharmaceutical Co – ADR, primarily from US and UK based news sources.

Thinking Of Investing In Takeda Pharmaceutical Company Limited (NYSE: TAK) Stock? Read This First

Thursday, 17 November 2022, 21:00:00
Takeda Pharmaceutical Company Limited (NYSE:TAK) shares, rose in value on Thursday, November 17, with the stock price up by 0.69% to the previous day’s close as strong demand from buyers drove the stock to $13.86. Actively observing the price movement in the recent trading, the stock is buoying the session at $13.77, falling within a … Thinking Of Investing In Takeda Pharmaceutical Company Limited (NYSE: TAK) Stock? Read This First Read More »
— Stocks Register

Takeda”s Iclusig beats Novartis Glivec in phase 3 leukemia trial (NYSE:TAK)

Thursday, 17 November 2022, 15:36:20
Takeda Pharmaceutical (TAK) said Iclusig met the main goal of a phase 3 trial in patients with newly-diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+…
— Seeking Alpha

Takeda Pharmaceutical Company Limited (TAK) Q2 2022 Earnings Call Transcript

Thursday, 27 October 2022, 20:44:11
Takeda Pharmaceutical Company Limited (NYSE:NYSE:TAK) Q2 2022 Results Conference Call October 27, 2022 5:30 AM ET Company Participants Ayako Iwamuro – IR Christophe Weber – President and…
— Seeking Alpha

Takeda Posts Lower 1H Profit, Lifts FY22 Outlook

Thursday, 27 October 2022, 14:46:40
Takeda Pharmaceutical Co Ltd”s (NYSE: TAK ) first-half net profit declined 9.2% from the prior year to ¥166.8 billion . Earnings per share fell 8.1% to ¥108. Core net profit grew 9.2% Y/Y to ¥446.7 billion, and core earnings per share were up 34.6% to ¥288. Revenue increased by 10.1% to ¥1.97 trillion. Core revenues climbed 19%, and core revenues at constant exchange rates grew … Full story available on
— Benzinga

Takeda Becomes First Enterprise to Achieve Diamond Tier Status as a Best in Resilience Certified Organization

Thursday, 27 October 2022, 14:35:00
Everbridge, the global leader in critical event management (CEM) solutions, today announced that Takeda Pharmaceutical Company Limited (“Takeda”) is the first enterprise to achieve Diamond Tier status as a Best in Resilience certified organization. The recognition is based on Takeda’s performance among peer companies in meeting the rigorous formalized standards to employing “best in class”
— Wallstreet:Online

Trading broker recommendation

We recommend that you check out as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: offer a large number of stocks for trading. Register an account today and check if they have TAK available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.